抗真菌治疗开发的进展和挑战
Emily Puumala1, Sara Fallah1, Nicole Robbins1
1Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Clinical microbiology reviews
|January 31, 2024
概括
全球真菌病的负担正在上升,治疗方法有限,抗真菌耐药性日益增加. 新的抗真菌策略和增加投资对于打击这种日益增长的传染病威胁至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 菌类学 菌类学是指菌类学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 全球真菌病负担急剧增加,每年估计导致150万死亡.
- 显著的诊断和临床理解差距可能低估了真实的真菌病的全球负担.
- 致病性真菌的抗真菌耐药性是一个日益严重和严重的问题,由有限数量的可用的抗真菌药物类别加剧.
研究的目的:
- 提供目前正在临床试验中的新型抗真菌治疗方法的全面概述.
- 突出新抗真菌剂的活性光谱和临床实施进展.
- 为了确定未来抗真菌药物开发的新兴细胞内点和途径.
主要方法:
- 对新的抗真菌治疗药物的当前临床试验数据的审查.
- 对有前途的抗真菌候选物的活性谱的分析.
- 描述新的细胞内蛋白质和途径作为潜在的抗真菌标.
主要成果:
- 在临床试验的各个阶段确定了几种新型抗真菌疗法.
- 评估这些新药物的进展和潜在的临床应用.
- 强调有希望的细胞内点,用于开发下一代抗真菌药物.
结论:
- 越来越多的真菌病和抗真菌耐药性的负担迫切需要开发新的抗真菌策略.
- 增加对抗真菌研究和开发的投资对于应对不断变化的传染病环境至关重要.
- 针对细胞内通路的新疗法为对抗耐药真菌感染提供了有希望的途径.
相关概念视频
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Drug Therapy
44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
44
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K


